Difference in activated partial thromboplastin time values with two different reagents according to C-reactive protein values
Activated partial thromboplastin time (APTT) is susceptible to reagent composition. This study aimed to investigate a large number of specimens and determine the cause of discrepancies. This study included 18,994 subjects who underwent coagulation tests at our hospital from May 2020 to December 2020...
Saved in:
Published in | Laboratory medicine Vol. 56; no. 1; pp. 7 - 14 |
---|---|
Main Authors | , , , |
Format | Journal Article |
Language | English |
Published |
England
Oxford University Press
06.01.2025
|
Subjects | |
Online Access | Get full text |
Cover
Loading…
Abstract | Activated partial thromboplastin time (APTT) is susceptible to reagent composition. This study aimed to investigate a large number of specimens and determine the cause of discrepancies.
This study included 18,994 subjects who underwent coagulation tests at our hospital from May 2020 to December 2020. Measuring reagents included HemosIL SynthASil APTT (APTT-SS, Instrumentation Laboratory) and Coagpia APTT-N (APTT-N, Sekisui Medical).
A total of 451 patients demonstrated APTT-N of >39 seconds and an APTT-N/SS ratio of >1.3. A C-reactive protein (CRP) level of ≥1.4 mg/L demonstrated a significant positive correlation, with a higher APTT-N/SS indicating higher CRP levels. All 28 subjects receiving no anticoagulants and who had remaining specimens underwent a cross-mixing test (CMT). Of them, 17 were suspected for lupus anticoagulant (LA) by both the waveform shape and the index of circulating anticoagulant (ICA) value, 6 by the ICA value, and 5 were difficult to determine.
This study revealed that the APTT-N prolongation correlated with CRP degree and the transient involvement of LA in CMT results due to CRP. This study indicated various reactivities depending on the assay reagents used. Further testing is warranted if LA is suspected, considering the patient's background. |
---|---|
AbstractList | Background Activated partial thromboplastin time (APTT) is susceptible to reagent composition. This study aimed to investigate a large number of specimens and determine the cause of discrepancies. Method This study included 18,994 subjects who underwent coagulation tests at our hospital from May 2020 to December 2020. Measuring reagents included HemosIL SynthASil APTT (APTT-SS, Instrumentation Laboratory) and Coagpia APTT-N (APTT-N, Sekisui Medical). Results A total of 451 patients demonstrated APTT-N of >39 seconds and an APTT-N/SS ratio of >1.3. A C-reactive protein (CRP) level of ≥1.4 mg/L demonstrated a significant positive correlation, with a higher APTT-N/SS indicating higher CRP levels. All 28 subjects receiving no anticoagulants and who had remaining specimens underwent a cross-mixing test (CMT). Of them, 17 were suspected for lupus anticoagulant (LA) by both the waveform shape and the index of circulating anticoagulant (ICA) value, 6 by the ICA value, and 5 were difficult to determine. Conclusion This study revealed that the APTT-N prolongation correlated with CRP degree and the transient involvement of LA in CMT results due to CRP. This study indicated various reactivities depending on the assay reagents used. Further testing is warranted if LA is suspected, considering the patient’s background. Activated partial thromboplastin time (APTT) is susceptible to reagent composition. This study aimed to investigate a large number of specimens and determine the cause of discrepancies. This study included 18,994 subjects who underwent coagulation tests at our hospital from May 2020 to December 2020. Measuring reagents included HemosIL SynthASil APTT (APTT-SS, Instrumentation Laboratory) and Coagpia APTT-N (APTT-N, Sekisui Medical). A total of 451 patients demonstrated APTT-N of >39 seconds and an APTT-N/SS ratio of >1.3. A C-reactive protein (CRP) level of ≥1.4 mg/L demonstrated a significant positive correlation, with a higher APTT-N/SS indicating higher CRP levels. All 28 subjects receiving no anticoagulants and who had remaining specimens underwent a cross-mixing test (CMT). Of them, 17 were suspected for lupus anticoagulant (LA) by both the waveform shape and the index of circulating anticoagulant (ICA) value, 6 by the ICA value, and 5 were difficult to determine. This study revealed that the APTT-N prolongation correlated with CRP degree and the transient involvement of LA in CMT results due to CRP. This study indicated various reactivities depending on the assay reagents used. Further testing is warranted if LA is suspected, considering the patient's background. Activated partial thromboplastin time (APTT) is susceptible to reagent composition. This study aimed to investigate a large number of specimens and determine the cause of discrepancies.BACKGROUNDActivated partial thromboplastin time (APTT) is susceptible to reagent composition. This study aimed to investigate a large number of specimens and determine the cause of discrepancies.This study included 18,994 subjects who underwent coagulation tests at our hospital from May 2020 to December 2020. Measuring reagents included HemosIL SynthASil APTT (APTT-SS, Instrumentation Laboratory) and Coagpia APTT-N (APTT-N, Sekisui Medical).METHODThis study included 18,994 subjects who underwent coagulation tests at our hospital from May 2020 to December 2020. Measuring reagents included HemosIL SynthASil APTT (APTT-SS, Instrumentation Laboratory) and Coagpia APTT-N (APTT-N, Sekisui Medical).A total of 451 patients demonstrated APTT-N of >39 seconds and an APTT-N/SS ratio of >1.3. A C-reactive protein (CRP) level of ≥1.4 mg/L demonstrated a significant positive correlation, with a higher APTT-N/SS indicating higher CRP levels. All 28 subjects receiving no anticoagulants and who had remaining specimens underwent a cross-mixing test (CMT). Of them, 17 were suspected for lupus anticoagulant (LA) by both the waveform shape and the index of circulating anticoagulant (ICA) value, 6 by the ICA value, and 5 were difficult to determine.RESULTSA total of 451 patients demonstrated APTT-N of >39 seconds and an APTT-N/SS ratio of >1.3. A C-reactive protein (CRP) level of ≥1.4 mg/L demonstrated a significant positive correlation, with a higher APTT-N/SS indicating higher CRP levels. All 28 subjects receiving no anticoagulants and who had remaining specimens underwent a cross-mixing test (CMT). Of them, 17 were suspected for lupus anticoagulant (LA) by both the waveform shape and the index of circulating anticoagulant (ICA) value, 6 by the ICA value, and 5 were difficult to determine.This study revealed that the APTT-N prolongation correlated with CRP degree and the transient involvement of LA in CMT results due to CRP. This study indicated various reactivities depending on the assay reagents used. Further testing is warranted if LA is suspected, considering the patient's background.CONCLUSIONThis study revealed that the APTT-N prolongation correlated with CRP degree and the transient involvement of LA in CMT results due to CRP. This study indicated various reactivities depending on the assay reagents used. Further testing is warranted if LA is suspected, considering the patient's background. |
Author | Ishihara, Yuya Doi, Hiroki Sato, Seiko Ito, Hiroyasu |
Author_xml | – sequence: 1 givenname: Yuya surname: Ishihara fullname: Ishihara, Yuya – sequence: 2 givenname: Hiroki surname: Doi fullname: Doi, Hiroki – sequence: 3 givenname: Seiko surname: Sato fullname: Sato, Seiko – sequence: 4 givenname: Hiroyasu surname: Ito fullname: Ito, Hiroyasu |
BackLink | https://www.ncbi.nlm.nih.gov/pubmed/39213365$$D View this record in MEDLINE/PubMed |
BookMark | eNpdkT1v2zAQhonCQe0kXTsWBLpkkXP8EsWxcJukQIAsySzQ1ClhIIkuSTvo0P8eCnY7dDrc4cFzh3vPyWIKExLymcGagRHXg92O2F0Po0VQ4gNZMSNFpbWABVkBgK4UcL0k5ym9llaamn8kS2E4E6JWK_Lnu-97jDg5pH6i1mV_sBk7urMxezvQ_BLDuA27waZcgOxHpAc77DHRN59faH4LtDs5Mo1on0tNReRC7Pz0THOgm6rMZzPSXQwZi-eouCRnvR0SfjrVC_J08-Nxc1fdP9z-3Hy7rxzXTa7QKKkMV7p20jSgamCuh0Ywq7a6EdZgB8i6WgvegN6CUrZvJHClXCMtl-KCXB29Zf2vsje3o08Oh8FOGPapFWBmr-R1Qb_-h76GfZzKda3gEmrGuJqFX07Ufv5_u4t-tPF3-_exBVgfARdDShH7fwiDdk6uPSbXnpIT706mjdM |
Cites_doi | 10.1172/JCI18921 10.1111/jth.15264 10.1136/jcp.38.2.133 10.1111/ijlh.12499 10.1111/joim.13126 10.1002/jcla.22415 10.1111/ijlh.13277 10.1002/jcla.24608 10.1007/s11239-021-02591-4 10.2147/JBM.S273047 10.1111/j.1365-2141.2011.08990.x 10.1056/NEJMc2013656 10.1055/s-0041-1729856 10.1002/art.10187 10.1155/2014/320674 10.1111/j.1538-7836.2006.01753.x 10.1016/j.ab.2009.04.037 10.5847/wjem.j.1920-8642.2011.01.014 10.1111/jth.13243 10.1002/rth2.12245 10.1111/ijlh.14003 10.1186/s12877-022-03327-6 10.1056/NEJMra1705454 10.1002/rth2.12090 10.1111/jth.15047 10.1111/j.1538-7836.2012.04906.x 10.1016/j.jtha.2022.11.011 10.1111/j.1365-2516.2009.02108.x 10.1002/jcla.22571 10.1093/labmed/lmx050 10.1111/jth.14980 10.1007/s11926-009-0075-4 10.1002/rth2.12809 10.7759/cureus.8349 10.1046/j.1365-2141.1999.01596.x 10.1007/s11239-021-02485-5 10.1016/s0969-2126(99)80023-9 10.1136/jcp.49.1.10 10.1016/j.clinbiochem.2022.01.010 |
ContentType | Journal Article |
Copyright | The Author(s) 2024. Published by Oxford University Press on behalf of American Society for Clinical Pathology. All rights reserved. For commercial re-use, please contact reprints@oup.com for reprints and translation rights for reprints. All other permissions can be obtained through our RightsLink service via the Permissions link on the article page on our site—for further information please contact journals.permissions@oup.com. |
Copyright_xml | – notice: The Author(s) 2024. Published by Oxford University Press on behalf of American Society for Clinical Pathology. All rights reserved. For commercial re-use, please contact reprints@oup.com for reprints and translation rights for reprints. All other permissions can be obtained through our RightsLink service via the Permissions link on the article page on our site—for further information please contact journals.permissions@oup.com. |
DBID | AAYXX CITATION NPM K9. NAPCQ 7X8 |
DOI | 10.1093/labmed/lmae053 |
DatabaseName | CrossRef PubMed ProQuest Health & Medical Complete (Alumni) Nursing & Allied Health Premium MEDLINE - Academic |
DatabaseTitle | CrossRef PubMed ProQuest Health & Medical Complete (Alumni) Nursing & Allied Health Premium MEDLINE - Academic |
DatabaseTitleList | ProQuest Health & Medical Complete (Alumni) PubMed MEDLINE - Academic |
Database_xml | – sequence: 1 dbid: NPM name: PubMed url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed sourceTypes: Index Database |
DeliveryMethod | fulltext_linktorsrc |
Discipline | Medicine |
EISSN | 1943-7730 |
EndPage | 14 |
ExternalDocumentID | 39213365 10_1093_labmed_lmae053 |
Genre | Journal Article |
GroupedDBID | --- 04C 0R~ 4.4 48X 5GY 5WD 6PF 7RV 7X7 AABZA AACZT AAILS AAMVS AAPQZ AAPXW AARHZ AAUAY AAVAP AAWTL AAYXX ABDFA ABEJV ABEUO ABGNP ABIXL ABJNI ABNHQ ABPPZ ABPQP ABPTD ABQNK ABVGC ABWST ABXVV ACGFS ACUFI ACYHN ADBBV ADCFL ADGZP ADHKW ADIPN ADNBA ADQBN ADRTK ADVEK AEHKS AEMDU AEMQT AENEX AENZO AEPUE AETBJ AEWNT AFFZL AFIYH AFOFC AFXAL AGINJ AGORE AGQXC AGSYK AGUTN AHGBF AHMBA AHMMS AJBYB AJEEA AJNCP ALIPV ALMA_UNASSIGNED_HOLDINGS ALUQC ALXQX APIBT ATGXG AVWKF BAYMD BCRHZ BENPR BEYMZ BHONS BTRTY BVRKM C45 CDBKE CITATION CS3 DAKXR DILTD DU5 EBS ENERS EX3 F5P FECEO FLUFQ FOEOM FOTVD FQBLK GAUVT GJXCC H13 IAO J21 JXSIZ KOP KQ8 KSI KSN MHKGH NAPCQ NOMLY NOYVH O9- OAUYM OAWHX OCZFY ODMLO OJQWA OJZSN OK1 OPAEJ OVD OWPYF PAFKI PEELM ROX ROZ RUSNO TEORI TJX TPV TR2 TWZ WH7 WOW YAYTL YHZ YKOAZ YROCO YXANX NPM K9. 7X8 |
ID | FETCH-LOGICAL-c278t-e954592576c49805601cf0831a5b783a9ed0e1d6732807b055af840255c84a243 |
ISSN | 0007-5027 1943-7730 |
IngestDate | Fri Jul 11 12:02:44 EDT 2025 Wed Aug 20 03:11:07 EDT 2025 Thu Apr 03 06:59:59 EDT 2025 Tue Jul 01 03:32:57 EDT 2025 |
IsPeerReviewed | true |
IsScholarly | true |
Issue | 1 |
Keywords | C-reactive protein lupus anticoagulant phospholipid activated partial thromboplastin time coagulation APTT prolongation |
Language | English |
License | https://academic.oup.com/pages/standard-publication-reuse-rights The Author(s) 2024. Published by Oxford University Press on behalf of American Society for Clinical Pathology. All rights reserved. For commercial re-use, please contact reprints@oup.com for reprints and translation rights for reprints. All other permissions can be obtained through our RightsLink service via the Permissions link on the article page on our site—for further information please contact journals.permissions@oup.com. |
LinkModel | OpenURL |
MergedId | FETCHMERGED-LOGICAL-c278t-e954592576c49805601cf0831a5b783a9ed0e1d6732807b055af840255c84a243 |
Notes | ObjectType-Article-1 SourceType-Scholarly Journals-1 ObjectType-Feature-2 content type line 14 content type line 23 |
PMID | 39213365 |
PQID | 3240611254 |
PQPubID | 105466 |
PageCount | 8 |
ParticipantIDs | proquest_miscellaneous_3099805426 proquest_journals_3240611254 pubmed_primary_39213365 crossref_primary_10_1093_labmed_lmae053 |
ProviderPackageCode | CITATION AAYXX |
PublicationCentury | 2000 |
PublicationDate | 2025-Jan-06 |
PublicationDateYYYYMMDD | 2025-01-06 |
PublicationDate_xml | – month: 01 year: 2025 text: 2025-Jan-06 day: 06 |
PublicationDecade | 2020 |
PublicationPlace | England |
PublicationPlace_xml | – name: England – name: Chicago |
PublicationTitle | Laboratory medicine |
PublicationTitleAlternate | Lab Med |
PublicationYear | 2025 |
Publisher | Oxford University Press |
Publisher_xml | – name: Oxford University Press |
References | Trimaille (2025010605545442200_CIT0038) 2022; 53 Wu (2025010605545442200_CIT0010) 2022; 22 Kim (2025010605545442200_CIT0040) 2022; 45 Kitchen (2025010605545442200_CIT0015) 1996; 49 Pineton de Chambrun (2025010605545442200_CIT0034) 2021; 289 Favaloro (2025010605545442200_CIT0039) 2022; 48 Kumano (2025010605545442200_CIT0021) 2019; 3 Garcia (2025010605545442200_CIT0030) 2018; 378 Harzallah (2025010605545442200_CIT0035) 2020; 18 Yasui (2025010605545442200_CIT0024) 2022; 36 Pepys (2025010605545442200_CIT0025) 2003; 111 Adenaeuer (2025010605545442200_CIT0003) 2023; 21 Toulon (2025010605545442200_CIT0016) 2016; 38 Cervera (2025010605545442200_CIT0029) 2002; 46 Chen (2025010605545442200_CIT0009) 2011; 2 Krone (2025010605545442200_CIT0032) 2010; 12 Winter (2025010605545442200_CIT0001) 2017; 48 Thompson (2025010605545442200_CIT0026) 1999; 7 Wilmot (2025010605545442200_CIT0019) 2020; 42 Christopeit (2025010605545442200_CIT0027) 2009; 391 Fliervoet (2025010605545442200_CIT0014) 2022; 104 Liu (2025010605545442200_CIT0023) 2018; 32 Devreese (2025010605545442200_CIT0033) 2020; 18 Bowles (2025010605545442200_CIT0036) 2020; 383 Kumano (2025010605545442200_CIT0012) 2012; 10 (2025010605545442200_CIT0011) 1985; 38 Ay (2025010605545442200_CIT0005) 2010; 16 Toulon (2025010605545442200_CIT0018) 2021; 19 Ng (2025010605545442200_CIT0031) 2018; 2 Jacobs (2025010605545442200_CIT0006) 2022; 53 De Jong (2025010605545442200_CIT0004) 2016; 14 Miyakis (2025010605545442200_CIT0028) 2006; 4 Yasin (2025010605545442200_CIT0002) 2020; 12 Kitchen (2025010605545442200_CIT0017) 1999; 106 Erez (2025010605545442200_CIT0007) 2022; 13 Noordermeer (2025010605545442200_CIT0037) 2022; 6 Sakurai (2025010605545442200_CIT0020) 2014; 2014 Falay (2025010605545442200_CIT0013) 2018; 32 van Rossum (2025010605545442200_CIT0022) 2012; 157 Neutze (2025010605545442200_CIT0008) 2016; 93 |
References_xml | – volume: 111 start-page: 1805 issue: 12 year: 2003 ident: 2025010605545442200_CIT0025 article-title: C-reactive protein: a critical update publication-title: J Clin Invest. doi: 10.1172/JCI18921 – volume: 19 start-page: 2002 issue: 8 year: 2021 ident: 2025010605545442200_CIT0018 article-title: APTT therapeutic range for monitoring unfractionated heparin therapy. Significant impact of the anti-Xa reagent used for correlation publication-title: J Thromb Haemost doi: 10.1111/jth.15264 – volume: 38 start-page: 133 issue: 2 year: 1985 ident: 2025010605545442200_CIT0011 article-title: ICSH/ICTH recommendations for reporting prothrombin time in oral anticoagulant control publication-title: J Clin Pathol. doi: 10.1136/jcp.38.2.133 – volume: 38 start-page: 389 issue: 4 year: 2016 ident: 2025010605545442200_CIT0016 article-title: In vitro sensitivity of different activated partial thromboplastin time reagents to mild clotting factor deficiencies publication-title: Int J Lab Hematol. doi: 10.1111/ijlh.12499 – volume: 289 start-page: 422 issue: 3 year: 2021 ident: 2025010605545442200_CIT0034 article-title: High frequency of antiphospholipid antibodies in critically ill COVID-19 patients: a link with hypercoagulability publication-title: J Intern Med. doi: 10.1111/joim.13126 – volume: 32 start-page: e22415 issue: 6 year: 2018 ident: 2025010605545442200_CIT0013 article-title: What should be the laboratory approach against isolated prolongation of a activated partial thromboplastin time publication-title: J Clin Lab Anal. doi: 10.1002/jcla.22415 – volume: 42 start-page: 810 issue: 6 year: 2020 ident: 2025010605545442200_CIT0019 article-title: The traceability of commercial plasma calibrators to the plasma international standards for factor VIII and factor IX publication-title: Int J Lab Hematol. doi: 10.1111/ijlh.13277 – volume: 36 start-page: e24608 issue: 9 year: 2022 ident: 2025010605545442200_CIT0024 article-title: Comparative analysis on characteristics of two activated partial thromboplastin time reagents publication-title: J Clin Lab Anal. doi: 10.1002/jcla.24608 – volume: 53 start-page: 945 issue: 4 year: 2022 ident: 2025010605545442200_CIT0006 article-title: Concomitant factor VIII inhibitor and lupus anticoagulant in an asymptomatic patient publication-title: J Thromb Thrombolysis. doi: 10.1007/s11239-021-02591-4 – volume: 13 start-page: 21 issue: 1 year: 2022 ident: 2025010605545442200_CIT0007 article-title: DIC in pregnancy – pathophysiology, clinical characteristics, diagnostic scores, and treatments publication-title: J Blood Med doi: 10.2147/JBM.S273047 – volume: 157 start-page: 394 issue: 3 year: 2012 ident: 2025010605545442200_CIT0022 article-title: False prolongation of the activated partial thromboplastin time (aPTT) in inflammatory patients: interference of C-reactive protein publication-title: Br J Haematol. doi: 10.1111/j.1365-2141.2011.08990.x – volume: 383 start-page: 288 issue: 3 year: 2020 ident: 2025010605545442200_CIT0036 article-title: Lupus anticoagulant and abnormal coagulation tests in patients with Covid-19 publication-title: N Engl J Med. doi: 10.1056/NEJMc2013656 – volume: 48 start-page: 55 issue: 1 year: 2022 ident: 2025010605545442200_CIT0039 article-title: Is lupus anticoagulant a significant feature of COVID-19? A critical appraisal of the literature publication-title: Semin Thromb Hemost. doi: 10.1055/s-0041-1729856 – volume: 46 start-page: 1019 issue: 4 year: 2002 ident: 2025010605545442200_CIT0029 article-title: Antiphospholipid syndrome: clinical and immunologic manifestations and patterns of disease expression in a cohort of 1,000 patients publication-title: Arthritis Rheum. doi: 10.1002/art.10187 – volume: 2014 start-page: 320674 year: 2014 ident: 2025010605545442200_CIT0020 article-title: Acquired hemophilia A: a frequently overlooked autoimmune hemorrhagic disorder publication-title: J Immunol Res doi: 10.1155/2014/320674 – volume: 4 start-page: 295 issue: 2 year: 2006 ident: 2025010605545442200_CIT0028 article-title: International consensus statement on an update of the classification criteria for definite antiphospholipid syndrome (APS) publication-title: J Thromb Haemost doi: 10.1111/j.1538-7836.2006.01753.x – volume: 391 start-page: 39 issue: 1 year: 2009 ident: 2025010605545442200_CIT0027 article-title: Characterization of Ca2+ and phosphocholine interactions with C-reactive protein using a surface plasmon resonance biosensor publication-title: Anal Biochem. doi: 10.1016/j.ab.2009.04.037 – volume: 2 start-page: 73 issue: 1 year: 2011 ident: 2025010605545442200_CIT0009 article-title: Treatment of vitamin K-dependent coagulation factor deficiency and subarachnoid hemorrhage publication-title: World J Emerg Med doi: 10.5847/wjem.j.1920-8642.2011.01.014 – volume: 14 start-page: 449 issue: 3 year: 2016 ident: 2025010605545442200_CIT0004 article-title: Developments in the diagnostic procedures for von Willebrand disease publication-title: J Thromb Haemost doi: 10.1111/jth.13243 – volume: 3 start-page: 695 issue: 4 year: 2019 ident: 2025010605545442200_CIT0021 article-title: Ruling out lupus anticoagulants with mixing test–specific cutoff assessment and the index of circulating anticoagulant publication-title: Res Pract Thromb Haemost doi: 10.1002/rth2.12245 – volume: 45 start-page: 163 issue: 2 year: 2022 ident: 2025010605545442200_CIT0040 article-title: Lupus anticoagulants as a prospective independent predictor in COVID-19 patients publication-title: Int J Lab Hematol. doi: 10.1111/ijlh.14003 – volume: 93 start-page: 279 issue: 4 year: 2016 ident: 2025010605545442200_CIT0008 article-title: Clinical evaluation of bleeding and bruising in primary care publication-title: Am Fam Physician. – volume: 22 start-page: 628 issue: 1 year: 2022 ident: 2025010605545442200_CIT0010 article-title: Neglected vitamin K deficiency causing coagulation dysfunction in an older patient with pneumonia: a case report publication-title: BMC Geriatr. doi: 10.1186/s12877-022-03327-6 – volume: 378 start-page: 2010 issue: 21 year: 2018 ident: 2025010605545442200_CIT0030 article-title: Diagnosis and management of the antiphospholipid syndrome publication-title: N Engl J Med. doi: 10.1056/NEJMra1705454 – volume: 2 start-page: 380 issue: 2 year: 2018 ident: 2025010605545442200_CIT0031 article-title: Effects of anti-β2GPI antibodies on VWF release from human umbilical vein endothelial cells and ADAMTS13 activity publication-title: Res Pract Thromb Haemost doi: 10.1002/rth2.12090 – volume: 18 start-page: 2828 issue: 11 year: 2020 ident: 2025010605545442200_CIT0033 article-title: Guidance from the Scientific and Standardization Committee for Lupus Anticoagulant/Antiphospholipid Antibodies of the International Society on Thrombosis and Haemostasis: update of the guidelines for lupus anticoagulant detection and interpretation publication-title: J Thromb Haemost doi: 10.1111/jth.15047 – volume: 10 start-page: 2338 issue: 11 year: 2012 ident: 2025010605545442200_CIT0012 article-title: APTT reagent with ellagic acid as activator shows adequate lupus anticoagulant sensitivity in comparison to silica-based reagent publication-title: J Thromb Haemost doi: 10.1111/j.1538-7836.2012.04906.x – volume: 21 start-page: 237 issue: 2 year: 2023 ident: 2025010605545442200_CIT0003 article-title: Severe high-molecular-weight kininogen deficiency: clinical characteristics, deficiency-causing KNG1 variants, and estimated prevalence publication-title: J Thromb Haemost. doi: 10.1016/j.jtha.2022.11.011 – volume: 16 start-page: 111 issue: 1 year: 2010 ident: 2025010605545442200_CIT0005 article-title: Determinants of factor VIII plasma levels in carriers of haemophilia A and in control women publication-title: Haemophilia doi: 10.1111/j.1365-2516.2009.02108.x – volume: 32 start-page: e22571 issue: 8 year: 2018 ident: 2025010605545442200_CIT0023 article-title: The analysis of false prolongation of the activated partial thromboplastin time (activator: silica): interference of C-reactive protein publication-title: J Clin Lab Anal. doi: 10.1002/jcla.22571 – volume: 48 start-page: 295 issue: 4 year: 2017 ident: 2025010605545442200_CIT0001 article-title: Coagulation testing in the core laboratory publication-title: Lab Med. doi: 10.1093/labmed/lmx050 – volume: 18 start-page: E3 issue: 9 year: 2020 ident: 2025010605545442200_CIT0035 article-title: Lupus anticoagulant is frequent in patients with Covid-19: response to reply publication-title: J Thromb Haemost. doi: 10.1111/jth.14980 – volume: 12 start-page: 53 issue: 1 year: 2010 ident: 2025010605545442200_CIT0032 article-title: Impaired fibrinolysis in the antiphospholipid syndrome publication-title: Curr Rheumatol Rep. doi: 10.1007/s11926-009-0075-4 – volume: 6 start-page: e12809 issue: 6 year: 2022 ident: 2025010605545442200_CIT0037 article-title: Lupus anticoagulant associates with thrombosis in patients with COVID-19 admitted to intensive care units: a retrospective cohort study publication-title: Res Pract Thromb Haemost doi: 10.1002/rth2.12809 – volume: 12 start-page: e8349 issue: 5 year: 2020 ident: 2025010605545442200_CIT0002 article-title: Diagnostic pearls and clinical implications of Prekallikrein deficiency publication-title: Cureus doi: 10.7759/cureus.8349 – volume: 106 start-page: 801 issue: 3 year: 1999 ident: 2025010605545442200_CIT0017 article-title: Lipid composition of seven APTT reagents in relation to heparin sensitivity publication-title: Br J Haematol. doi: 10.1046/j.1365-2141.1999.01596.x – volume: 53 start-page: 228 issue: 1 year: 2022 ident: 2025010605545442200_CIT0038 article-title: Transient endothelial injury and release of lupus anticoagulant in COVID-19 publication-title: J Thromb Thrombolysis. doi: 10.1007/s11239-021-02485-5 – volume: 7 start-page: 169 issue: 2 year: 1999 ident: 2025010605545442200_CIT0026 article-title: The physiological structure of human C-reactive protein and its complex with phosphocholine publication-title: Structure. doi: 10.1016/s0969-2126(99)80023-9 – volume: 49 start-page: 10 issue: 1 year: 1996 ident: 2025010605545442200_CIT0015 article-title: Wide variability in the sensitivity of APTT reagents for monitoring of heparin dosage publication-title: J Clin Pathol. doi: 10.1136/jcp.49.1.10 – volume: 104 start-page: 30 year: 2022 ident: 2025010605545442200_CIT0014 article-title: Comparison of capillary and venous blood sampling for routine coagulation assays publication-title: Clin Biochem. doi: 10.1016/j.clinbiochem.2022.01.010 |
SSID | ssj0004962 |
Score | 2.3304007 |
Snippet | Activated partial thromboplastin time (APTT) is susceptible to reagent composition. This study aimed to investigate a large number of specimens and determine... Background Activated partial thromboplastin time (APTT) is susceptible to reagent composition. This study aimed to investigate a large number of specimens and... |
SourceID | proquest pubmed crossref |
SourceType | Aggregation Database Index Database |
StartPage | 7 |
SubjectTerms | Anticoagulants C-reactive protein Reagents |
Title | Difference in activated partial thromboplastin time values with two different reagents according to C-reactive protein values |
URI | https://www.ncbi.nlm.nih.gov/pubmed/39213365 https://www.proquest.com/docview/3240611254 https://www.proquest.com/docview/3099805426 |
Volume | 56 |
hasFullText | 1 |
inHoldings | 1 |
isFullTextHit | |
isPrint | |
link | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV3db9MwELfKkBAvCMZXYSAjIfFQhaWxnY9HtK3aoBtCaqW-RU7ismg0qboUNCSe-be5sx2nhYGAlyhyrUvq--X8O9t3R8jLEEiIr5LAK4bz3OPA37wsw7OuoVRMBnHhc4x3Pj0Lj6f87UzMer3vG6eW1k32Ov96bVzJ_2gV2kCvGCX7D5p1QqEB7kG_cAUNw_WvdHxoq5vkOvMHhih8lsggl9gXT5Gfr-pFVi-BITd4nrFcqAFm91Y2pq35UrsKKc0A6ONHHe8mc3RJdRxVPTjwoF0bxYHO6QByjIhNWjs2UML9-p83608uz0tMCq1t_frKzQKHtamXXa7qi9Kt80hd1QksWHlROwmmDXteSVOnpV2nCIRepwg7r_b6-Mct2xx5wjeZAlrbbJKOb2HQGNpoY8Y2Uai_zAUmTxZ8SwtcNh59Wkgsg9HNe-1e_9n7dDQdj9PJ0Wxyg9wMAK9YCuPdh42080lo0s7bV3TZP9m-kb9vpW-zm9-4LJq6TO6SO9bnoG8MgO6Rnqp2ya1Tq6j75FuHI1pW1OGIWhzRbRxRxBE1IKCIIwo4og5HtMURdTiiTU07HFGLIyviAZmOjiYHx54ty-HlQRQ3nkqAdSfoqOY8iX106fM5FqyTIotiJhNV-GpYhJgGyo8yXwg5jzn6rnnMZcDZQ7JT1ZV6TGjApBBC5UHBEx5lcZKxnGWKicJPFOdRn7xqhzNdmuwrqTk1wVIz8Kkd-D7Za0c7tV_oZco0XQUKz_vkhfsZ7CduislK1WvoAy4S_Akgqn3yyGjJPQp8hyFjoXjyZ-FPye0O8Htkp1mt1TOgqk32XMPoB2A0nkQ |
linkProvider | Colorado Alliance of Research Libraries |
openUrl | ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Difference+in+activated+partial+thromboplastin+time+values+with+two+different+reagents+according+to+C-reactive+protein+values&rft.jtitle=Laboratory+medicine&rft.au=Ishihara%2C+Yuya&rft.au=Doi%2C+Hiroki&rft.au=Sato%2C+Seiko&rft.au=Ito%2C+Hiroyasu&rft.date=2025-01-06&rft.pub=Oxford+University+Press&rft.issn=0007-5027&rft.volume=56&rft.issue=1&rft.spage=7&rft.epage=14&rft_id=info:doi/10.1093%2Flabmed%2Flmae053&rft.externalDBID=NO_FULL_TEXT |
thumbnail_l | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=0007-5027&client=summon |
thumbnail_m | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=0007-5027&client=summon |
thumbnail_s | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=0007-5027&client=summon |